Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Mesenchymal Transition”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Ended earlyNCT01441128
What this trial is testing

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungAdenocarcinomaCarcinoma, Squamous Cell+1 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Testing effectiveness (Phase 2)Ended earlyNCT04515394
What this trial is testing

Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)

Who this might be right for
Colorectal Neoplasms
EMD Serono Research & Development Institute, Inc. 3
Not applicableUnknownNCT01927354
What this trial is testing

Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.

Who this might be right for
Head-and-Neck Squamous Cell Carcinoma
National Taiwan University Hospital 100
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Early research (Phase 1)Looking for participantsNCT07181681
What this trial is testing

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumor
BeOne Medicines 63
Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Not applicableStudy completedNCT06055660
What this trial is testing

Moesin Expression in Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 50
Large-scale testing (Phase 3)Looking for participantsNCT06417008
What this trial is testing

HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 1,080
Not applicableUnknownNCT05995067
What this trial is testing

The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

Who this might be right for
Periodontal Disease, AVDC Stage 3and 4Epithelial Mesenchymal TransitionLong Noncoding RNA
Ali A Abdulkareem 48
Early research (Phase 1)Study completedNCT03021642
What this trial is testing

Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers

Who this might be right for
Healthy
Merck KGaA, Darmstadt, Germany 24
Not applicableUnknownNCT03509779
What this trial is testing

Pronostic and Predictive Value of EMT in Localized Lung Cancer

Who this might be right for
NSCLC, Stage I, II, IIIA, IIIBSurgeryProgression+1 more
European Georges Pompidou Hospital 1,000
Not applicableUnknownNCT04137406
What this trial is testing

Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis

Who this might be right for
Breast CancerLymph Node Metastases
Peking University People's Hospital 160
Testing effectiveness (Phase 2)Ended earlyNCT04926831
What this trial is testing

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 4
Not applicableStudy completedNCT04021394
What this trial is testing

Influence of EMT on CTCs and Disease Progression in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 31
Not applicableNot Yet RecruitingNCT07529639
What this trial is testing

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Who this might be right for
Urothelial Bladder CarcinomaBladder CarcinomaNon-Muscle-Invasive Bladder Cancer (NMIBC)+1 more
Assiut University 100
Not applicableLooking for participantsNCT05832541
What this trial is testing

Expression of Epithelial-Mesenchymal Transition Associated Markers in Peri-implant Tissues

Who this might be right for
Peri-implantitis
University of Baghdad 40
Post-approval studies (Phase 4)UnknownNCT01111422
What this trial is testing

Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients

Who this might be right for
End-Stage Kidney DiseasePeritoneal Dialysis
Ewha Womans University 66
Testing effectiveness (Phase 2)Looking for participantsNCT04077099
What this trial is testing

REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Regeneron Pharmaceuticals 231
Load More Results